• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18691

【品名】4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine

【CA登记号】7357-67-7

【 分 子 式 】C7H14ClNO

【 分 子 量 】163.647

【元素组成】C 51.38% H 8.62% Cl 21.66% N 8.56% O 9.78%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(VIII)

Monodemethylation of 6,7-dimethoxyquinazolin-4(3H)-one (I) in refluxing methanesulfonic acid in the presence of L-methionine provides 6-hydroxy-7-methoxyquinazolin-4(3H)-one (II), which is acetylated with acetic anhydride and pyridine at 100 C to give the acetate (III). Treatment of compound (III) with refluxing SOCl2 and a catalytic amount of DMF yields chloride (IV), which by condensation with 3-chloro-4-fluoroaniline (V) in boiling isopropanol affords the anilinoquinazoline (VI). Hydrolysis of the acetate group of (VI) by treatment with NH4OH in refluxing MeOH gives the 6-hydroxyquinazoline derivative (VII), which finally is alkylated with 3-(4-morpholinyl)-propyl chloride (VIII) or 3-(4-morpholinyl)propyl bromide (IX).

1 Gibson, K.H.; Grundy, W.; Barker, A.J.; et al.; Studies leading to the identification of ZD1839 (Iressa(TM)): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 2001, 11, 14, 1911.
2 D'Souza, N.; Castañer, J.; Levin, M.; Iressa. Drugs Fut 2002, 27, 4, 339.
3 Gibson, K.H. (AstraZeneca plc); Quinazoline derivs.. EP 0823900; JP 1999504033; US 5770599; WO 9633980 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(II) 18685 6-hydroxy-7-methoxy-4(3H)-quinazolinone 179688-52-9 C9H8N2O3 详情 详情
(III) 18686 7-methoxy-4-oxo-3,4-dihydro-6-quinazolinyl acetate 179688-53-0 C11H10N2O4 详情 详情
(IV) 18687 4-chloro-7-methoxy-6-quinazolinyl acetate 230955-75-6 C11H9ClN2O3 详情 详情
(V) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(VI) 18689 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl acetate 788136-89-0 C17H13ClFN3O3 详情 详情
(VII) 18690 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinol 184475-71-6 C15H11ClFN3O2 详情 详情
(VIII) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(IX) 52653 4-(3-bromopropyl)morpholine 125422-83-5 C7H14BrNO 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

The alkylation of 4-hydroxy-3-methoxybenzoic acid methyl ester (I) with 3-(4-morpholinyl)propyl chloride (II) and tetrabutylammonium chloride in refluxing butanone gives 3-methoxy-4-[3-(4-morpholinyl)propoxy]benzoic acid methyl ester (III), which is nitrated with HNO3 in hot acetic acid to yield 5-methoxy-4-[3-(4-morpholinyl)propoxy]-2-nitrobenzoic acid methyl ester (IV). The reduction of (III) with H2 over Pd/C in methanol/ethyl acetate to afford the corresponding 2-amino ester (V), which is condensed with dimethylformamide dimethylacetal (VI) by heating at 100 C to provide the 2-(dimethylaminomethyleneamino) derivative (VII). The cyclization of (VII) with acetonitrile (VIII) by means of BuLi and CO2 in THF gives 6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-oxo-1,4-dihydroquinoline-3-carbonitrile (IX), which is treated with refluxing SOCl2 to yield the 4-chloroquinoline derivative (X). Finally, this compound is condensed with 2-bromo-5-methoxyaniline by means of pyridine hydrochloride in 2-ethoxyethanol or NaH in THF (or DMF).

1 Wang, Y.D.; et al.; Inhibition of SRC kinase activity by 4-phenylamino-3-quinolinecarbonitriles, Part 1: optimization of the aniline headpiece at C-4. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 144.
2 Tsou, H.-R.; Wissner, A.; Johnson, B.D.; Reich, M.F.; Floyd, M.B. Jr.; Kitchen, D.B. (American Cyanamid Co.); Substituted 3-cyano quinolines. US 6002008 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29176 methyl 4-hydroxy-3-methoxybenzoate 3943-74-6 C9H10O4 详情 详情
(II) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(III) 50321 methyl 3-methoxy-4-[3-(4-morpholinyl)propoxy]benzoate C16H23NO5 详情 详情
(IV) 50322 methyl 5-methoxy-4-[3-(4-morpholinyl)propoxy]-2-nitrobenzoate C16H22N2O7 详情 详情
(V) 50323 methyl 2-amino-5-methoxy-4-[3-(4-morpholinyl)propoxy]benzoate C16H24N2O5 详情 详情
(VI) 11984 N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal 4637-24-5 C5H13NO2 详情 详情
(VII) 50324 methyl 2-[[(E)-(dimethylamino)methylidene]amino]-5-methoxy-4-[3-(4-morpholinyl)propoxy]benzoate C19H29N3O5 详情 详情
(VIII) 50327 Cyanoethane; Ethyl cyanide; Propionitrile 107-12-0 C26H39NO5 详情 详情
(IX) 50325 6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-oxo-1,4-dihydro-3-quinolinecarbonitrile C18H21N3O4 详情 详情
(X) 48517 4-chloro-6-methoxy-7-[3-(4-morpholinyl)propoxy]-3-quinolinecarbonitrile C18H20ClN3O3 详情 详情
(XI) 50326 2-Bromo-5-methoxyaniline 129968-11-2 C7H8BrNO 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

 

1 Chandregowda V,Rao GV, Reddy GC. 2007. One-pot conversion of 2-nitrobenzonitriles to quinazolin-4(3H)-ones and synthesis of gefitinib and erlotinib hydrochloride. Heterocycles,71(1): 39~48
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(III) 66437 4-methoxy-3-(3-morpholinopropoxy)benzaldehyde 861453-11-4 C15H21NO4 详情 详情
(IV) 66444 (Z)-4-methoxy-3-(3-morpholinopropoxy)benzaldehyde oxime   C15H22N2O4 详情 详情
(V) 66433 4-methoxy-3-(3-morpholinopropoxy)benzonitrile   C15H20N2O3 详情 详情
(VI) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(VII) 66445 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one   C16H21N3O4 详情 详情
(VIII) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情

合成路线4

该中间体在本合成路线中的序号:(VII)

 

1 Knesl P.Roeseling D,Jordis U 2006. Improved synthesis of substituted 6,7-rdihydroxy-4iuinazolinearninest: tandutinib, erlotinib and gefitinib. Molecules, 11(4):286~297
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 65853 5-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one; 5-Hydroxy-7-methoxy-3H-quinazolin-4-one   C9H8N2O3 详情 详情
(II) 66446 7-methoxy-4-oxo-1,4-dihydroquinazolin-6-yl acetate   C11H10N2O4 详情 详情
(III) 18687 4-chloro-7-methoxy-6-quinazolinyl acetate 230955-75-6 C11H9ClN2O3 详情 详情
(IV) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(V) 66447 4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate hydrochloride;6-Acetoxy-4-(3-chloro-4-fluoroanilino)-7-methoxyquinazoline hydrochloride  184475-70-5 C17H13ClFN3O3.HCl 详情 详情
(VI) 18690 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinol 184475-71-6 C15H11ClFN3O2 详情 详情
(VII) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

 

1 Wang JQ, Gao MZ, Miller KD, et al.2006. Synthesis of (11 C) iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase. Bioorg Med Chem Lett, 16 (15): 4102~4106
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54574 3-hydroxy-4-methoxybenzonitrile 52805-46-6 C8H7NO2 详情 详情
(II) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(III) 66433 4-methoxy-3-(3-morpholinopropoxy)benzonitrile   C15H20N2O3 详情 详情
(IV) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(V) 66435 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile 675126-27-9 C15H21N3O3 详情 详情
(VI) 66441 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide   C15H23N3O4 详情 详情
(VII) 66445 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one   C16H21N3O4 详情 详情
(VIII) 66443 4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine   C16H20ClN3O3 详情 详情
(IX) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(X) 66448 4-((3-chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol  847949-49-9 C21H22ClFN4O3 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XII)

Reaction of 2-nitrovanillin (III) with NH4OH and I2 in H2O/THF yields nitrile (XVIII), which is then condensed with 4-(3-chloropropyl)morpholine hydrochloride (XII) —prepared by alkylation of morpholine (XIX) with 1-bromo-3-chloropropane (XX) in toluene at 84 °C— by means of Cs2CO3 in DMF at 75 °C to give the morpholinopropyl ether (XXI). Reduction of the nitro group in compound (XXI) with Fe and AcOH affords amine (XXII), which by cyclization with ethylenediamine (VII) and sulfur at 100 °C produces the imidazoline derivative (XXIII). Finally, aminoimidazoline (XXIII) is then subjected to ring closure with cyanogen bromide (IX) in the presence of Et3N in CH2Cl2 .

1 Hentemann, M., Wood, J., Scott, W. et al. (Bayer Pharmaceuticals Corp.). Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. EP 2096919, JP 2010511718, US 2011083984, US 8466283, US 201326113, WO 2008070150.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 68129 2-nitrovanillin;4-Hydroxy-3-methoxy-2-nitrobenzaldehyde   C8H7NO5 详情 详情
(VII) 14754 ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine 107-15-3 C2H8N2 详情 详情
(IX) 28017 cyanic bromide;cyanogen bromide 506-68-3 CBrN 详情 详情
(XII) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(XIII) 68137 7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine   C18H25N5O3 详情 详情
(XVIII) 68140 4-hydroxy-3-methoxy-2-nitrobenzonitrile   C8H6N2O4 详情 详情
(XIX) 10388 Morpholine 110-91-8 C4H9NO 详情 详情
(XX) 10358 1-Bromo-3-chloropropane 109-70-6 C3H6BrCl 详情 详情
(XXI) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(XXII) 66435 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile 675126-27-9 C15H21N3O3 详情 详情
(XXIII) 68141 6-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxy-3-(3-morpholinopropoxy)aniline   C17H26N4O3 详情 详情
Extended Information